Modulation of Macrophage Hyperactivity Improves Survival in a Burn-Sepsis Model

Archives of Surgery

Volumn 127, Issue 2, 1992, Pages 152-158

  O'riordain, Micheal G ^a   Collins, Kathryn H ^a   Pilz, Michael ^a   Saporoschetz, Inna B ^a   Mannick, John A ^a   Rodrick, Mary L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; BURN; CONFERENCE PAPER; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL;

ANIMAL; BURNS; INDOMETHACIN; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED A; MICE, INBRED STRAINS; SEPTICEMIA; SPLEEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE; TUMOR NECROSIS FACTOR;

EID: 0026526093     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1992.01420020034005     Document Type: Article

References (36)

1. Johnston RB. Current concepts: immunology: monocytes and macrophages. N Engl J Med. 1988;318:747-752.
2. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319-326.
3. Balkwill FR, Burke F. The cytokine network. Immunol Today. 1989;10:299-304.
4. Fong Y, Moldawer LL, Shires GT, Lowry SF. The biological characteristics of cytokines and their implications in surgical injury. Surg Gynecol Obst. 1990;170:363-378.
5. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin-6, interleukin-1 and fatal outcome. J Exp Med. 1989; 169:333-338.
6. Beutler B, Milsark I, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229:869-871.
7. Yim JH, Terawi A, Pearce MK, Zou JC, Abrams JS, Starnes HF. Monoclonal antibody against murine L-6 prevents lethal effects of Escherichia coli sepsis and tumor necrosis factor challenge in mice. Surg Forum. 1990;41:114-116.
8. Oliff A, Defeo-Jones D, Boyer M, et al. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987; 50:555-563.
9. Gough DB. Educate the phagocyte. Br J Surg. 1991;78:1-2.
10. Hansbrough J, Peterson V, Kortz E, Piacentine J. Post burn immunosuppression in an animal model: monocyte dysfunction induced by trauma patients' monocytes. Surgery. 1983;93:415-423.
11. Takayama TK, Miller C, Szabo G. Elevated tumor necrosis factor alpha production concomitant to elevated prostaglandin E2 production by trauma patients' monocytes. Arch Surg. 1990;125:29-35.
12. Moss NM, Gough DB, Jordan AL, Grbic JT, Rodrick ML, Mannick JA. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery. 1988;104:882-887.
13. Gearing AJ, Bird CR, Bristow A, Poole S, Thorpe R. A sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods. 1987;99:7-11.
14. Sheehan KC, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol. 1989; 142:3884-3893.
15. Silver GM, Gamelli RD, O'Reilly M, Hebert JC. The effect of interleukin-1 alpha on survival in a murine model of burn wound sepsis. Arch Surg. 1990;125:922-925.
16. Alexander HR, Langstein HN, Doherty GM, Jensen JC, Norton JA. Human recombinant tumor necrosis factor (hrTNF) protection against endotoxin-induced shock and lethality in the rat. Surg Forum. 1990;41:103-105.
17. West MA, Billiar TR, Mazuski JE, Curran RJ, Cerra FB, Simmons RL. Endotoxin modulation of hepatocyte secretory and cellular protein synthesis is mediated by Kupffer cells. Arch Surg. 1988;123:1400-1405.
18. Callery MP, Kamei R, Mangino MJ, Flye MW. Organ interactions in sepsis: host defense and the hepatic-pulmonary macrophage axis. Arch Surg. 1991;126:28-32.
19. Border JR. Hypothermia, sepsis multiple systems organ failure and the macrophage. Arch Surg. 1988;123:285-286.
20. Oppenheim JJ, Charon JA, Luger TA. Evidence for an in vivo inflammatory role of interleukin-1 (IL-1). Transplant Proc. 1982;14:553-555.
21. Mochizuki DY, Eisenman JR, Conlon PJ, Larsen AD, Tushinski RJ. Interleukin-1 regulates hemopoietic activity, a role previously ascribed to hemopoietin-1. Proc Natl Acad Sci USA. 1987;84:5267-5271.
22. Lichtman AH, Chin J, Schmidt JA, Abbas AK. Role of interleukin-1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A. 1988;85:9699-9703.
23. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin-1 induces a shock-like effect in rabbits: synergism with tumor necrosis factor and the effects of cyclooxygenase inhibition. J Clin Invest. 1988;81:1162-1172.
24. Callery MP, Kamei T, Flye MW. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch Surg. 1990;125:36-41.
25. Kunkel SL, Chensue SW, Phan SH. Prostaglandins as endogenous mediators of interleukin-1 production. J Immunol. 1986;136:186-192.
26. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988; 263:5380-5384.
27. Renz H, Gong JH, Schmidt A, Nain M, Gemsa D. Release of tumor necrosis factor alpha from macrophages: enhancement and suppression are dose dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol. 1988;141:2388-2393.
28. Spengler RN, Spengler ML, Streiter RM, Remick DG, Larrick JW, Kunkel SL. Modulation of tumor necrosis factor-alpha gene expression: desensitization of prostaglandin E2-induced suppression. J Immunol. 1989;142:4346-4350.
29. Dinarello CA, Ikejima T, Warner SJC, et al. Interleukin-1 induces interleukin-1, I: induction of circulating interleukin-1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol. 1987;139:1902-1910.
30. Sanchez-Cantu L, Rode HN, Christou NV. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg. 1989;124:1432-1436.
31. Gough DB, Moss NM, Jordan A, Grbic JT, Rodrick ML, Mannick JA. Recombinant interleukin-2 (rIL-2) improves immune response and host resistance to septic challenge in thermally injured mice. Surgery. 1988;104:292-300.
32. Burchett SK, Weaver WM, Westall JA, Larsen A, Kronheim S, Wilson CB. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol. 1988;140:3473-3481.
33. Ghezzi P, Dinarello CA. IL-1 induces IL-1, III: specific inhibition of IL-1 production by IFN-gamma. J Immunol. 1988;140:4238-4244.
34. Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986;233:652-654.
35. Sprung CL, Caralis PV, Marcial EH, et al. The effects of high dose corticosteroids in patients with septic shock: a prospective controlled study. N Engl J Med. 1984;311:1137.
36. te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood. 1990;76:1392-1397.